State of Alaska Department of Revenue raised its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 80.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,690 shares of the company’s stock after buying an additional 1,650 shares during the period. State of Alaska Department of Revenue’s holdings in Phibro Animal Health Corporation were worth $136,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock valued at $48,597,000 after buying an additional 130,935 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Phibro Animal Health Corporation by 0.9% in the first quarter. Wellington Management Group LLP now owns 1,385,325 shares of the company’s stock worth $38,928,000 after buying an additional 11,950 shares during the last quarter. State Street Corp raised its position in shares of Phibro Animal Health Corporation by 6.1% in the first quarter. State Street Corp now owns 489,093 shares of the company’s stock worth $13,745,000 after buying an additional 28,273 shares during the last quarter. Dimensional Fund Advisors LP raised its position in shares of Phibro Animal Health Corporation by 12.3% in the first quarter. Dimensional Fund Advisors LP now owns 396,007 shares of the company’s stock worth $11,128,000 after buying an additional 43,260 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Phibro Animal Health Corporation by 13.3% in the first quarter. Bank of New York Mellon Corp now owns 347,657 shares of the company’s stock worth $9,769,000 after buying an additional 40,735 shares during the last quarter. Hedge funds and other institutional investors own 47.41% of the company’s stock.

Shares of Phibro Animal Health Corporation (PAHC) traded up 0.51% during trading on Friday, reaching $39.50. 18,620 shares of the company were exchanged. The company’s 50-day moving average is $37.96 and its 200 day moving average is $32.15. The firm has a market capitalization of $1.57 billion, a PE ratio of 24.53 and a beta of 1.35. Phibro Animal Health Corporation has a 1-year low of $20.14 and a 1-year high of $39.95.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its earnings results on Monday, May 8th. The company reported $0.37 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.37. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The company had revenue of $190 million during the quarter, compared to analysts’ expectations of $185.90 million. During the same quarter in the prior year, the company posted $0.38 earnings per share. Phibro Animal Health Corporation’s revenue for the quarter was up 3.5% compared to the same quarter last year. Equities research analysts expect that Phibro Animal Health Corporation will post $1.45 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a yield of 1.02%. Phibro Animal Health Corporation’s payout ratio is 24.69%.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/state-of-alaska-department-of-revenue-acquires-1650-shares-of-phibro-animal-health-corporation-pahc/1475829.html.

A number of equities analysts recently weighed in on the stock. Piper Jaffray Companies set a $35.00 price objective on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a report on Thursday, May 11th. Finally, Credit Suisse Group lowered shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and boosted their price objective for the stock from $29.00 to $36.00 in a report on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Phibro Animal Health Corporation has a consensus rating of “Hold” and a consensus target price of $30.50.

In related news, insider Jack Bendheim sold 48,000 shares of the stock in a transaction that occurred on Friday, June 23rd. The shares were sold at an average price of $37.15, for a total transaction of $1,783,200.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Bfi Co., Llc sold 16,000 shares of the stock in a transaction that occurred on Thursday, July 6th. The shares were sold at an average price of $36.00, for a total transaction of $576,000.00. Following the sale, the insider now directly owns 28,000 shares of the company’s stock, valued at approximately $1,008,000. The disclosure for this sale can be found here. Insiders have sold 352,000 shares of company stock valued at $12,599,200 in the last three months. 48.09% of the stock is currently owned by corporate insiders.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.